Vita Genomics, Inc. is one of the top ten influencers of life science industry in the AsiaˇVPacific region. Vita Genomics, centered in Taiwan and China, aims to be a premier genomics-based biotechnological and biopharmaceutical company. The company focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. We are now initiating a drug rescue program designed to resurrect drugs that have failed in the previous clinical trials owing to low efficacies. This program applies pharmacogenomics approaches using biomarkers to screen subsets of patients who may respond better or avoid adverse responses to the test drugs. Vita Genomics, Inc. has envisioned itself as an important player in the healthcare industry offering advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. Please see the list of publications and the company profile of Vita Genomics (Pharmacogenomics, June 2007, Vol. 8, No. 6, Pages 669-673).

Vita Genomics, founded in March 2001, has established its headquarter in Taiwan and a wholly owned subsidiary GeneCore in Shanghai, China. Vita Genomics has envisioned itself to be an important player in the healthcare industry by offering advanced and targeted molecular diagnostic products and services, providing more efficient and safer medical solutions, improving the drug development process, and lowering the overall healthcare cost through the pharmacogenomics approaches.

Vita Genomics has already built up strong relationships with research institutions and medical organizations throughout Taiwan and China. We are constantly looking for pharmaceutical partners who can benefit from identifying patients for drug responsiveness prior to treatments, partners who would fund expanded pharmacogenomics studies that will enable us to validate the responsiveness of all significant genotypes, and partners who would co-develop DNA-based molecular diagnostic products.

Vita Genomics is an active participant in modernizing Taiwan healthcare system. We are establishing the infrastructure needed to add the molecular profile information to the healthcare integrated circuit (IC) card. This is a first step in creating personalized medicine in the future. In addition, Vita Genomics can act as the conduit between the western world and China because we have already established a beachhead in Shanghai. Vita Genomics follows the high standards of US FDA guidelines in collecting samples in conducting research and clinical studies.Vita Genomics concentrates on the elucidation of the genes and pathways involved in various diseases and on the drug responsiveness of patients in an attempt to improve the healthcare system.

ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@ˇ@

 

Customer Services: 886-2-8976-9501(24HR)

 

GeneCore